ORGANISATION MONDIALE DE LA SANTE
WORLD HEALTH ORGANIZATION
INTERNATIONAL AGENCY FOR RESEARCH ON CANCER
CENTRE INTERNATIONAL DE RECHERCHE SUR LE CANCER
Governing Council/
Conseil de Direction
GC/51/20
Fifty-first Session/
Cinquante et unième session
19/05/2009
Lyon, 14–15 May 2009/Lyon, 14–15 mai 2009
Auditorium
LIST OF REPRESENTATIVES – PARTICIPATING STATES
LISTE DES REPRESENTANTS – ETATS PARTICIPANTS
Norway
Norvège
Professor Lars E. Hanssen, Chairperson
/Président
Director General of Health
The Norwegian Board of Health
PO Box 8128 Dep
0032 Oslo
Alternate – Suppléante
Dr Henrietta Blankson
Senior Adviser
The Research Council of Norway
PO Box 2700 St Hanshaugen
0131 Oslo
Finland
Finlande
Professor Pekka Puska, Vice-Chairperson
/Vice-Président
Director-General
National Institute for Health and Welfare
Mannerheimintie 166
00300 Helsinki
Governing Council/Conseil de Direction Page 2
List of Representatives/
Liste des Représentants
GC/51/20
United Kingdom of Great Britain and Northern Ireland
Royaume-Uni de Grande-Bretagne et d’Irlande du Nord
Dr Mark Palmer,
Rapporteur
Head, International Strategy
Medical Research Council
20 Park Crescent
London W1B 1AL
Australia
Australie
Mr Sanjeev Commar
Australia's Minister-Counsellor (Health)
Permanent Mission of Australia to the
United Nations Office and other
International Organizations in Geneva
Chemin des Fins 2
Case postale 172
CH 1211 Geneva 19
Austria
Autriche
Ms Simone Mesner
Austrian Federal Ministry of
Science and Research
Head of Division
R&D Legal Development and Life Sciences
Rosengasse 4
1014 Vienna
Alternate – Suppléante
Dr Hemma Bauer
Austrian Federal Ministry of
Science and Research
Unit of Life Sciences
Rosengasse 4
1014 Vienna
Page 3 Governing Council/Conseil de Direction
GC/51/20 List of Representatives/
Liste des Représentants
Belgium
Belgique
Dr Margareta Haelterman
Médecin-collaborateur scientifique
Federal Public Services Public Health
Eurostation – Bloc II – Local 1D08D
Place Victor Horta 40 boîte 10
1060 Brussels
Canada
Dr Gloria Wiseman
Director, International Health Division
International Affairs Directorate
Strategic Policy Branch
Health Canada
Jeanne Mance Building, Tunney’s Pasture
Ottawa, Ontario K1A 0K9
Alternates – Suppléants
Dr Ariff Ally
A/Director, Bureau of Risk and Impact Assessment
Safe Environments Program
Healthy Environments and Consumer Safety Branch
Health Canada
Jeanne Mance Building, Tunney’s Pasture
Ottawa, Ontario K1A 0K9
Dr Christine Fitzgerald
Executive Vice-President
Canadian Institutes of Health Research
160 Elgin Street, 9th floor
Ottawa, ON K1A 0W9
Denmark
Danemark
Professor Herman Autrup
University of Aarhus School of Public Health
Bartholins Alle 2
8000 Aarhus
Governing Council/Conseil de Direction Page 4
List of Representatives/
Liste des Représentants
GC/51/20
France
Madame Pascale Flamant
Directrice générale
Institut national du Cancer (INCa)
52 avenue André Morizet
F 92513 Boulogne-Billancourt
Alternates – Suppléants
Dr Raymond Pamphile
Conseiller scientifique pour les affaires internationales
auprès du Directeur général de la
recherche et de l’innovation
1 rue Descartes
75231 Paris Cedex 05
Dr Rosemary Ancelle-Park
Ministère de la Santé et des Solidarités
14 avenue Duquesne
75350 Paris 07SP
Dr Guilherme de Lemos
Ministère des Affaires étrangères
et Européennes
Pôle Santé
48 rue de Javel
75015 Paris
Germany
Allemagne
Dr Irene Keinhorst
Federal Ministry of Health
Friedrichstrasse108
10117 Berlin
Alternate – Suppléant
Mr Thomas Ifland
Federal Ministry of Health
Rochusstrasse 1
53123 Bonn
Page 5 Governing Council/Conseil de Direction
GC/51/20 List of Representatives/
Liste des Représentants
India
Inde
Dr R.K. Srivastava
Director General of Health Services
Government of India
Ministry of Health and Family Welfare
Nirman Bhawan
New Delhi, 110001
Ireland
Irlande
Dr John Devlin
Deputy Chief Medical Officer
Department of Health and Children
Hawkins House
Dublin 2
Italy
Italie
Dr Stefano Fais
Directeur de la Recherche
Institut supérieur de la Santé
Viale Regina Elena 299
00161 Rome
Japan
Japon
Dr Toshiyasu Shimizu
Deputy Director
International Affairs Division
Ministry of Health, Labour and Welfare
1-2-2 Kasumigaseki Chiyoda-ku
Tokyo 100-8916
1 / 9 100%